DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Granules India Ltd reports Q2, H1 FY27 results

EquityBulls 4 hrs ago·2 Nov 2026, 12:22 pm

Granules India

Granules India Ltd has reported its financial results for the second quarter and the first half of fiscal year 2027. The company, a key player in the pharmaceutical manufacturing sector, has released its performance data for this period.

For investors, these results are important as they provide an update on the company's operational health and financial trajectory. The figures will be scrutinized to assess Granules India's ability to maintain its growth momentum and manage costs in a competitive market.

Investors should watch for details on the company's order book, export performance, and any commentary on future outlook. These factors will be crucial in determining the stock's short-term and long-term investment potential.